Skip to main content
Search Query
Show Search
Home
Ways to Listen
On Air: Frequencies & Streams
On Air: Frequencies & Streams
Programs
A-Z
KHSU Radio Schedule
Printable Schedule
A-Z
KHSU Radio Schedule
Printable Schedule
About
History + Mission
Transparency
Employment Opportunities
History + Mission
Transparency
Employment Opportunities
Contact
Support
Corporate Support
Donate
Donate Your Vehicle
Planned Giving
KHSU Endowment
Corporate Support
Donate
Donate Your Vehicle
Planned Giving
KHSU Endowment
BBC
About KHSU-BBC
Program Schedule
About KHSU-BBC
Program Schedule
Radio Bilingüe
Radio Bilingüe
Listen Live
Radio Bilingüe
Listen Live
Community Calendar
© 2026 KHSU
Menu
Show Search
Search Query
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00
0:00
Available On Air Stations
On Air
Now Playing
KHSU (MP3)
On Air
Now Playing
KHSU (AAC)
On Air
Now Playing
Radio Bilingüe (AAC)"
On Air
Now Playing
Radio Bilingüe (MP3)"
All Streams
Home
Ways to Listen
On Air: Frequencies & Streams
On Air: Frequencies & Streams
Programs
A-Z
KHSU Radio Schedule
Printable Schedule
A-Z
KHSU Radio Schedule
Printable Schedule
About
History + Mission
Transparency
Employment Opportunities
History + Mission
Transparency
Employment Opportunities
Contact
Support
Corporate Support
Donate
Donate Your Vehicle
Planned Giving
KHSU Endowment
Corporate Support
Donate
Donate Your Vehicle
Planned Giving
KHSU Endowment
BBC
About KHSU-BBC
Program Schedule
About KHSU-BBC
Program Schedule
Radio Bilingüe
Radio Bilingüe
Listen Live
Radio Bilingüe
Listen Live
Community Calendar
Search results for
Sort By
Relevance
Newest (Publish Date)
Oldest (Publish Date)
Search
With Rafael Nadal retiring, what's the future of men's professional tennis?
NPR's Scott Detrow speaks with sports journalist Reem Abulleil, Rafael Nadal's impact on men's tennis and what the sport could look like as top players retire.
Listen
•
3:46
This year's U.S. Open is a redemption of sorts for American Taylor Townsend
American tennis player Taylor Townsend is gearing up for the U.S. Open. She'll take to the court as the top-ranked doubles player. Her story is one of resilience and overcoming preconceived notions.
Listen
•
3:42
Coffee prices are higher than ever. Here's what it means for your cup
Droughts in top coffee-growing countries have shrunk the supply of beans. Supermarket brands like Nescafé and Folgers have already raised prices — but the world keeps drinking more and more coffee.
Listen
•
3:45
Israel says it killed a Hezbollah commander in Beirut it blames for a deadly strike
The Israeli military says it "eliminated" a top Hezbollah commander in a suburb of Lebanon's capital in retaliation for a deadly rocket attack in the Israeli-controlled Golan Heights.
Listen
•
3:46
Hakeem Jeffries could be the first Black speaker of the House. First, he needs to win
House Minority Leader Hakeem Jeffries is campaigning in competitive districts across the U.S. with the goal of flipping control of the House of Representatives in the November election.
Listen
•
4:20
The Story Behind The Stunts: Remembering Hollywood's Hal Needham
Throughout his career, Needham did the kind of stunts that would either end with a spectacular shot ... or an ambulance. On Oct. 25, Needham died of cancer at age 82. We listen back to a 2011 interview, in which he tells the stories behind some of his most daring stunts.
Listen
•
26:15
Truman’s Faith, Niebuhr’s Doubt
The Harry Truman-Reinhold Niebuhr crossover lore.
Listen
•
59:00
The Supreme Court is again the focus of politics with its Trump immunity ruling
The Supreme Court's opinion granting broad immunity to former President Trump from prosecution will likely place the court at the center of the presidential campaign.
Listen
•
3:37
4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis
The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.
Listen
•
3:34
Moderna edges toward FDA emergency use authorization for pediatric COVID-19 vaccine
Moderna says a low-dose version of its vaccine is safe and effective for kids, including those under age 6. The company plans to ask the Food and Drug Administration for emergency authorization.
Listen
•
4:08
Previous
580 of 6,414
Next